Serum Krebs von den Lungen-6 as a potential biomarker for distinguishing combined pulmonary fibrosis and emphysema from chronic obstructive pulmonary disease: A retrospective study
2024 · Heliyon · 1 citations
https://doi.org/10.1016/j.heliyon.2024.e35099